US Stock MarketDetailed Quotes
KRRO Korro Bio
- 47.360
- -1.020-2.11%
Close Jul 23 16:00 ET
- 47.360
- 0.0000.00%
Post 16:02 ET
439.17MMarket Cap-4677P/E (TTM)
49.300High46.900Low29.25KVolume48.430Open48.380Pre Close1.40MTurnover0.74%Turnover RatioLossP/E (Static)9.27MShares97.91052wk High2.90P/B186.41MFloat Cap9.15052wk Low--Dividend TTM3.94MShs Float2918.500Historical High--Div YieldTTM4.96%Amplitude9.150Historical Low47.827Avg Price1Lot Size
Korro Bio Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||
| Cash flow from continuing operating activities | -11.18%-21.89M | -25.42%-67.28M | -14.72M | -19.69M | -67.15%-53.65M | -32.09M |
| Net income from continuing operations | 0.24%-19.56M | -39.87%-81.17M | ---17.65M | ---19.61M | -164.27%-58.03M | ---21.96M |
| Operating gains losses | ---- | --65K | ---- | ---- | ---- | --8K |
| Depreciation and amortization | -10.26%726K | 44.56%3.63M | --917K | --809K | 57.43%2.51M | --1.6M |
| Other non cash items | 178.47%1.2M | 138.44%3.61M | --885K | --432K | 111.24%1.51M | ---13.47M |
| Change In working capital | -219.30%-5.13M | 776.62%4.28M | --742K | ---1.61M | -170.02%-633K | --904K |
| -Change in prepaid assets | 14.96%-290K | 2,096.43%559K | --242K | ---341K | 92.96%-28K | ---398K |
| -Change in payables and accrued expense | -1,243.84%-7.63M | 154.66%4.37M | --694K | ---568K | -14.92%1.72M | --2.02M |
| -Change in other current assets | 4,400.00%86K | -1,515.45%-1.99M | ---- | ---2K | -324.14%-123K | ---29K |
| -Change in other current liabilities | 489.78%2.71M | 161.01%1.34M | ---209K | ---695K | ---2.2M | --0 |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---686K |
| Cash from discontinued investing activities | ||||||
| Operating cash flow | -11.18%-21.89M | -25.42%-67.28M | ---14.72M | ---19.69M | -67.15%-53.65M | ---32.09M |
| Investing cash flow | ||||||
| Cash flow from continuing investing activities | -136.23%-5.61M | 0.94%11.16M | -3.42M | 15.49M | 128.00%11.06M | -39.5M |
| Net PPE purchase and sale | -270.85%-5.61M | -50.35%-7.84M | ---4.42M | ---1.51M | -17.55%-5.21M | ---4.43M |
| Net investment purchase and sale | --0 | 16.76%19M | --1M | --17M | 146.40%16.27M | ---35.07M |
| Cash from discontinued investing activities | ||||||
| Investing cash flow | -136.23%-5.61M | 0.94%11.16M | ---3.42M | --15.49M | 128.00%11.06M | ---39.5M |
| Financing cash flow | ||||||
| Cash flow from continuing financing activities | -99.69%139K | 1,043,016.67%187.76M | -36K | 45.4M | -99.98%18K | 115.95M |
| Net common stock issuance | ---- | --117.25M | ---- | ---- | --0 | ---- |
| Net preferred stock issuance | --0 | --45.46M | ---42K | --45.5M | --0 | --115.95M |
| Proceeds from stock option exercised by employees | 172.55%139K | 1,032.26%702K | --82K | --51K | 121.43%62K | --28K |
| Net other financing activities | ---- | 55,443.18%24.35M | ---76K | ---150K | -46.67%-44K | ---30K |
| Cash from discontinued financing activities | ||||||
| Financing cash flow | -99.69%139K | 1,043,016.67%187.76M | ---36K | --45.4M | -99.98%18K | --115.95M |
| Net cash flow | ||||||
| Beginning cash position | 317.39%173.12M | -50.65%41.48M | --82.68M | --41.48M | 111.73%84.04M | --39.69M |
| Current changes in cash | -166.42%-27.36M | 409.26%131.64M | ---18.17M | --41.2M | -195.98%-42.57M | --44.35M |
| End cash Position | 76.30%145.76M | 317.39%173.12M | --64.5M | --82.68M | -50.65%41.48M | --84.04M |
| Free cash flow | -29.71%-27.5M | -27.63%-75.12M | ---19.14M | ---21.2M | -61.07%-58.86M | ---36.54M |
| Currency Unit | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg